Bitome offers noninvasive Dx tools for real-time volume status monitoring.
Bitome is a two-year-old, Boston-based connected med device company. Its first product is a noninvasive tool for monitoring hydration status with broad applications across the dialysis, diabetic, sports performance, and maternal / fetal monitoring spaces. In a first application, Bitome’s technology will precisely assess volume status in congestive heart failure (CHF) patients – a key, but hard to measure, biometric correlated with patient outcomes. In short, Bitome wants to use hydration monitoring technology to do for CHF, what glucose monitoring has done for diabetes.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 6, 2020 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
| Mar 28, 2018 | Convertable Note | — | 1 | — | — | Detail |
| Oct 17, 2016 | Convertable Note | — | 1 | — | — | Detail |
| Aug 24, 2016 | Seed | — | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |
HAX
|
— | Convertable Note |